Jade Biosciences (JBIO) EPS (Basic) (2020 - 2026)
Jade Biosciences (JBIO) reported EPS (Basic) of -$0.57 for Q1 2026, up 95.29% on a YoY basis from -$0.29 in Q1 2025, and down 418.18% quarter-over-quarter from -$0.11 in Q4 2025.
Jade Biosciences (JBIO) EPS (Basic) (2020 - 2026) Analysis & Trends
Jade Biosciences has reported EPS (Basic) for 7 years, with the latest figure at -$0.57 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 95.29% year-over-year to -$0.57; the trailing twelve-month figure through Mar 2026 stood at -$2.02 (up 93.75% YoY), and the FY2025 full-year result was -$3.19, down 30.74% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.57, down from -$0.11 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.11 in Q4 2025, with the low at -$14.89 in Q4 2024.
- Historically, EPS (Basic) has averaged -$2.36 across 5 years, with a median of -$0.67 in 2023.
- Annual changes were most pronounced in 2024 — EPS (Basic) slumped 1912.16% — and 2025, when it surged 99.26%.
- Jade Biosciences' EPS (Basic) stood at -$0.61 in 2022, then slipped by 21.31% to -$0.74 in 2023, then tumbled by 1912.16% to -$14.89 in 2024, then surged by 99.26% to -$0.11 in 2025, then slumped by 418.18% to -$0.57 in 2026.
- The last three EPS (Basic) figures came in at -$0.57 (Q1 2026), -$0.11 (Q4 2025), and -$0.48 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Jade Biosciences | 973.55 Mn | 973.55 Mn | - | -0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.57 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.48 |
| Jun 30, 2025 | -0.86 |
| Mar 31, 2025 | -12.10 |
| Dec 31, 2024 | -14.89 |
| Sep 30, 2024 | -5.16 |
| Jun 30, 2024 | -0.19 |
| Mar 31, 2024 | -0.83 |
| Dec 31, 2023 | -0.74 |
| Sep 30, 2023 | -0.71 |
| Jun 30, 2023 | -0.76 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -0.61 |
| Sep 30, 2022 | -0.56 |
| Jun 30, 2022 | -0.49 |
| Mar 31, 2022 | -0.45 |
| Dec 31, 2021 | -0.07 |
| Sep 30, 2021 | -0.26 |
| Jun 30, 2021 | -23.80 |